Verition Fund Management’s CVS Health CVS Stock Holding History

Verition Fund Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.22M	Sell	17,000 -900	-5%	-$69.3K	0.01%	1239
2025 Q4	$1.42M	Sell	17,900 -4,300	-19%	-$339K	0.01%	1883
2025 Q3	$1.67M	Buy	22,200 +12,300	+124%	+$843K	0.01%	2122
2025 Q2	$683K	Buy	+9,900	New	+$649K	﹤0.01%	2742
2024 Q2	–	Sell	-29,600	Closed	-$2.36M	–	3033
2024 Q1	$2.36M	Buy	29,600 +22,100	+295%	+$1.69M	0.02%	1119
2023 Q4	$592K	Buy	7,500 +3,200	+74%	+$228K	﹤0.01%	1428
2023 Q3	$300K	Sell	4,300 -3,700	-46%	-$262K	﹤0.01%	1732
2023 Q2	$553K	Buy	+8,000	New	+$569K	0.01%	1185
2022 Q4	–	Sell	-13,500	Closed	-$1.29M	–	2261
2022 Q3	$1.29M	Buy	+13,500	New	+$1.34M	0.01%	1213
2022 Q2	–	Sell	-18,500	Closed	-$1.87M	–	2485
2022 Q1	$1.87M	Buy	18,500 +10,200	+123%	+$1.07M	0.02%	1020
2021 Q4	$856K	Buy	+8,300	New	+$767K	0.01%	1392
2019 Q3	–	Sell	-20,000	Closed	-$1.09M	–	1092
2019 Q2	$1.09M	Sell	20,000 -4,000	-17%	-$215K	0.03%	408
2019 Q1	$1.29M	Buy	24,000 +19,000	+380%	+$1.17M	0.05%	325
2018 Q4	$328K	Buy	+5,000	New	+$373K	0.02%	598

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Verition Fund Management's CVS Position: Q1 2026 in Review

Verition Fund Management reduced its CVS Health (CVS) stake by 7.6% in Q1 2026, selling an estimated $511K and leaving 80,760 shares worth $5.8M. The position accounts for 0.04% of the portfolio, ranked #519.

Verition Fund Management first reported a position in CVS in Q3 2013 and has held it in 41 quarters since. The position peaked at $22.7M in Q3 2023. 1,866 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

Verition Fund Management held 80,760 shares of CVS Health worth $5.8M as of Q1 2026.
Verition Fund Management sold 6,636 CVS Health shares in Q1 2026, an estimated $511K.
CVS Health made up 0.04% of Verition Fund Management's portfolio in Q1 2026, its #519 holding.
Verition Fund Management first reported a position in CVS Health in Q3 2013 and has held it in 41 quarters since.
Verition Fund Management's CVS Health position peaked at $22.7M in Q3 2023.
1,866 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.